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Abstract  
  unlike most other sedative drugs, 2 adrenoceptor  agonists e.g (clonidine) are 
capable of producing both sedation and analgesia with little if any, respiratory change.  
The aim of this study was to evaluate the analgesic efficacy, the respiratory and  the 
endocrine effects  of epidural versus intravenous clonidine for postoperative pain.  Forty 
adult patients ASA  I and II  of both sexes were scheduled for elective lower abdominal 
or lower extremity surgical  procedures.  For postoperative pain relief ,  the patients 
were randomly  divided into two groups, twenty  patient of each.   In (Group I)  patients 
received  intravenous  clonidine  through  patient-controlled  analgesia  pump  (IPCA).  In 
(Group  II)  patients  received  epidural  clonidine  through  patient-controlled  analgesia 
pump (EPCA). 
          A standard anaesthetic  technique was  employed to all  patients and  anaesthesia 
was  maintained  with  gas  oxygen  halothane  and  muscle  relaxant.    Serial  arterial  and 
venous blood samples were taken to measure blood gases and endorphin level. After 
surgery patients with visual analogue scale ( VAS ) >4 were given clonidine initial dose 
4µg/kg intravenous or epidural  infusion over a  period of 30  minutes then  they  were 
allowed to self administer clonidine using PCA pump which delivered a bolus dose of 
0.5µg/kg with a 15 minute lockout interval to the corresponding route. 
          Self-administered  doses  were  (124.2±34.637µg)  in  intravenous  group  and 
(100.6±31.406µg) in epidural group. The  total clonidine dose  was  (424. ±38.138µg) 
in intravenous group versus  (399.8±47.371µg) in epidural group.  Pain scores  were 
lower  after  than  before  clonidine  administration  in  both  groups  .      No  significant 
difference  in  pain  scores  were  found  between  the  two  groups.  There  was  also  no 
significant changes in respiratory rate, arterial  PH, Pa Co2 or Pa o2  in each studied 
group and no significant difference  between the two groups.      Forced vital    capacity 
(  FVC  )  and  Forced  expiratory  volume  in  one  second    (  FEV1  )  were  significantly 
reduced  before  clonidine  injection  in  both  groups.  The  beta  endorphin  level  was 
increased  after  one  hour  of  clonidine  administration  and  there  was  no  significant 
difference    between  the  two  groups.  In  conclusion  Clonidine  proves  to  be  adequate 
alternative to opiates without their side effects and the dose of clonidine is lower by the 
epidural  route. 
 
Introduction  
           There  is  great  evidence  that 
unrelieved  postoperative  pain  may 
result  in  harmful  physiological  and 
psychological  effects  and  good  pain 
relief  may  help  to  decrease  postop  -
erative  morbidity  (Ready,2000).      
Anaesthesia  and  surgery  are  associated 
with  dramatic  decrease  in  functional 
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residual  capacity  (FRC)  resulting  in 
basal  atelectasis  and  development  of 
pulmonary shunts (Jones et al., 1990) .   
Postoperative pain hinders patients from  
coughing  effectively  and  co-operating 
in chest physiotherapy (Stoelting 1999),  
that  may  decrease  the  tidal    volume 
(TV)  ,    vital  capacity  (VC)  and  peak 
expiratory  flow  rate  (PEFR).      Unlike 
most other sedative drugs, 2 adreno -
ceptor    agonists  are  capable  of  prod  -
ucing both sedation  and analgesia  with 
little if any, respiratory change (Bernard 
et al., 1995) that makes them potentially 
useful  in  the  postoperative  non 
ambulatory  settings  and  in  intensive 
care  situations  (Hall  et  al.,2001)  .  
Clonidine,  a  centrally  acting  2   
receptor  agonist  has  a  beneficial  effect 
before,  during  and  after  anaesthesia 
such as, sedation,  analgesia,   increased 
cardiovascular  stability  and  improved 
outcome  (Kamibayashi  and  Maze, 
2000) and (Fehretal., 2001). 
  There  is  currently  considerable 
interest  in  attempting  to  combine  the 
potent  analgesic  effects  of  drugs 
delivered  into  the  epidural  space  with 
the  advantage  of  patient  participation 
associated  with  the  patient-controlled-
analgesia (PCA) concept.  PCA system 
was  designed  whereby  patients  could 
administer  their  own  pain  relief  drug 
and  so  titrate  the  dose  to  their  own 
endpoint of adequate analgesia  (Kluges 
1990). 
  The  aim  of  this  study  was  to 
evaluate  the  analgesic  efficacy,  the 
respiratory and the endocrine effects  of 
epidural  versus  intravenous  clonidine 
for postoperative pain relief. 
 
Patients and Methods 
  Forty adult patients ASA  I and 
II    of  both  sexes  aged  between  18-55 
years admitted  to Al Zahraa university 
hospital and were scheduled for elective 
lower  abdominal  or  lower  extremity 
surgical  procedures.  For postoperative 
pain relief ,  the patients were randomly  
divided into two groups, twenty  patient 
of each: 
Group I:   Patients received intravenous 
clonidine through (IPCA)pump. 
Group  II  :  Patients  received  epidural 
clonidine through (EPCA )pump. 
  Patients  who  showed  evidence 
of  cardiovascular,  respiratory,  renal  or 
hepatic    dysfunction  and  patients  with 
abnormal  coagulation  profile  were 
excluded.  The  study  protocol  was 
explained  to  the  patients  taking  their 
consent.   Patients were instructed how 
to use the PCA device, and to describe 
the  threshold  of  postoperative  pain  on 
the visual analogue scale (VAS). 
 
Equipment : 
Patient-controlled analgesia  device :    a 
self  administered    analgesic  pump 
(Abbot life provider). 
  All  patients  in  the  two  groups 
received  5mg  midazolam  orally  at  the 
night of operation.   
Prior to induction of anaesthesia  : 
In  group  I  “18”  gauge  cannula  was 
placed for  clonidine injection and PCA 
device. 
In  group  II  :  a  lumbar  epidural 
technique  midline  approach  was 
employed  under  complete  aseptic 
conditions,  where  a  touhy  needle  was 
inserted between lumbar level L3 – L4  
or L4 – L5   interspace,  position of the 
needle  was  identified  by  loss  of 
resistance and an epidural catheter was 
introduced. 
         Induction  was  achieved  by  
thiopentone  4-6  mg/kg  and  succinyl-
choline  1  mg/kg  and  anaesthesia  was 
maintained  with  60%  nitrous  oxide  in 
oxygen, halothane 0.5 –1.5 %.   Muscle 
paralysis  was  achieved  by  atracurium  
0.5mg/kg  with controlled ventilation. 
         A 20 gauge cannula was inserted 
in  the  radial  artery  of  the  left  hand  of  
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the  patients  after  positive  Allen’s  test,  
and  flushed  with  heparinized    saline 
solution to allow serial measurements of 
arterial  blood  gases.      Intraoperative 
monitoring included :  ECG, non inva -
sive arterial  blood pressure, pulse oxi -
metry  and  capnography,    and    conti  -
nued 24 hour after clonidine  adminis -
tration  .    No  additional  analgesics  or 
tranquilizers were  administered imme -
diately after operation.  
         At  the  first  complaint  of  pain,   
patients  with  VA  S  >4    were  given 
clonidine (catapress) (Boehringer Inge -
lheim. UK.) as 150 µg/ml in  ampoules 
of 1 ml. 
         All  patients  received  an  initial 
loading  dose  of  4  µg/kg    clonidine 
intravenous or epidural infusion over  a 
period of 30 minute, then  the patients 
were allowed to self administer  cloni -
dine using  PCA  pump which  delive -
red a blouse dose of 0.5 µg/kg  with a 
15  minute  lockout  interval  to  the 
corresponding route.  Data were recor -
ded at the following times : 
         Before clonidine administration, at 
15  and  30  minutes  during  infusion  of 
loading dose 4µg/kg., and at 2, 4, 6, 8, 
12, 24 hours after the loading dose and 
during the use of PCA device. 
         Respiratory  rate  was  recorded. 
Arterial blood gases were measured by 
blood  gas  analyzer    [CHIRON 
Diagnostic  248  Rapid-lab]  before 
clonidine administration,   then 30 min,  
4  hours  and  24  hours  after  clonidine  
administration.. 
Pulmonary function tests were  done by 
Respirometer (Jaeger flowmate). Forced 
vital  capacity  (FVC)  and  forced 
expiratory  volume  in  one  second 
(FEV1) were  measured   preoperative, 
postoperative  during  pain,  12hr  and 
24hr after clonidine administration. 
Any  side  effects  were  observed  and 
treated  as  follow  :  hypotension  was 
treated by i.v.  fluids or 3 mg ephedrine 
i.v. Bradycardia was treated by 0.5 – 1 
mg atropine   i.v.Inadequate analgesia  : 
if  the  patient  required  analgesia  in 
addition  to  self-administered  doses  of 
clonidine. 
Sampling : Blood  samples were taken 
to  measure  plasma  level  of  beta-
endorphin. Samples time was  recorded 
before  administration  of  clonidine  and  
1 hour after the first dose of clonidine.  
Blood was collected in tubes containing 
EDTA and Trasylol (5000 Kiu  trasylol  
in 10 ml vacutainer tube). The samples 
were cooled in an ice-bath immediately, 
and  centrifuged  at  4°c.  The  plasma 
should be frozen  within one hour  and 
stored  at - 20°c until assay. Beta endo -
rphin  in  sample  was  extracted  using 
Sep-Pak C 18 cartridges.   The extracts 
were  analysed  by  competitive  radio 
immunoassay  using  antibody  against 
synthetic human B-endorphin. 
         B-endorphin  in  standards  and 
samples compete with   125  I   labelled 
B-endorphin  in  binding  to  the  antib  -
odies.  125  I  B-endorphin  binds  to  the 
antibodies  in  a  reverse  proportion  to 
concentration of B-endorphin in stand -
ards and samples.  Antibody bound 125 
I  B-endorphin  was  separated  from  the 
fraction  using    the  double  antibody 
polyethylen glycol precipitation techn –
ique, the radioactivity of the precipitates 
was  measured.  (Kits  supplied  from 
Gama trade company) 
Statistical analysis : 
All variables were expressed as mean ± 
SD.  Comparison of patients within the 
same  group  were  evaluated  by  using 
non-parametric  Wilcoxon  Signed-rank 
test.  Paired  simple  t-test  was  used  for  
comparison  between  groups.      P-value 
of  less  than  0.05  denote  a  significant 
difference.  
Results: 
         Demographic data  were  comp -
arable for age,  weight, height and sex 
as shown in table (1).  
Epidural versus intravenous clonidine …… 
 
  17  
There  were  no  significant  differences 
between the two groups. 
         The initial dose of clonidine  was 
identical  in  both  groups  (301.2±37. 
480µg)  in    the  intravenous  group  and 
(299.2±36.374µg) in the epidural group.  
But,  the  clonidine  dose  given  via  the 
PCA  device  to  achieve  a  comparable  
pain  relief  level  was  lower  in  epidural 
group. 
         Self-administered  dose  were 
(124.2±34.637µg) in intravenous group 
and  (100.6±31.406µg)  in  epidural 
group. 
          The    total  clonidine  dose    was  
(424. ±38.138µg) in intravenous group 
versus    (399.8±47.371µg)  in  epidural 
group (table 2) 
VAS before clonidine injection showed 
no significant difference in both groups 
(table 3). 
         Pain scores  were lower after than 
before  clonidine  administration  in  both 
groups  with  no  significant  difference 
between the two groups ( Figure 1). 
         Presence  of  pain  in  the  posto  -
perative  period  have  been  expected  to  
induce  an  alteration  in    pulmonary 
functions.  Respiratory  rate  was 
unchanged  throughout  the  study  for 
both groups.  Analgesia did not result in 
significant  changes  in  respiratory  rate 
(table 4).  There was also no significant 
change in arterial  PH, Pa Co2 or Pa o2  
in  each  studied  group  throughout  the 
observation  time  and  no  significance 
between the two groups (table 5),  but 
FVC  and  FEV,  were  significantly 
reduced    before    injection  of  clonidine 
in  both  groups  compared  to  baseline 
(preoperative)  spirometric  parameters 
(Figures  3&4  ).Eight  hours  post-
injection,  there were significant impro -
vement in pulmonary function tests but 
this improvement was still low than the 
baseline values till the end of the study 
(table 6)(Figures 3&4  ).  There were no 
statistical  significant  differences  in 
pulmonary function  tests between both 
groups (table  6  )   (Figures 3&4  ). 
         As  regards,  beta  endorphin,  both 
groups  showed  increase    in  plasma 
concentration    of  beta-endorphin  after 
one  hour  of  clonidine  administration.  
There  was  no  significant  difference 
between  both  groups    table  (7  ) 
Figures(4). 
Table 1  :Demographic data.  Values are represented as mean ± SD.  There are no 
significant differences between the two groups. 
 
  Group 1 (IPCA) 
N= 20 
Group1 (EPCA) 
N = 20 
Age (yr) 
Weight (kg) 
Height (cm) 
Sex (M/F 
32.2±10.30 
59.0±9.46 
163.4±10.11 
9/11 
29.4±8.70 
65.8±10.06 
165±9.50 
12/8 
 
Table 2 :Doses of clonidine in both groups values are represented as mean± SD. 
  P value < 0.05 between groups. 
 
  Group I  Group II 
Mean  ±SD  Mean  ±SD 
Initial dose 
Self-administered dose 
Total dose 
301.2 
124.2 
425.4 
±37.480 
±34.637 
±38.138 
299.2 
100.6 
399.8 
±36.374 
±31.406 
±57.371*  
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Table  3 : Visual analogue scale (VAS).  Values are represented as  mean ± SD.  There 
                are no significant differences between groups. 
 
time  Group I (IPCAA)  Group II(EPCA) 
Mean  SD  Mean  SD 
Before 
15min 
30min 
2hr 
4 hr 
6hr 
8hr 
12hr 
24hr 
8.6 
3.3 
2.5 
2.6 
2.9 
2.25 
2.7 
2.1 
1.9 
±0.94 
±0.75 
±0.60 
±0.55 
±0.68 
±0.76 
±0.44 
±0.58 
±0.64 
 
8.2 
3.3 
2.2 
1.8 
1.9 
2.1 
2.4 
2.3 
2.2 
±0.82 
±0.97 
±0.71 
±0.48 
±0.68 
±0.76 
±1.31 
±0.81 
±0.91 
 
 
 
 
Figure 1 :  Visual analogue scale (VAS). Values are represented as  mean. 
 
Table 4 : Respiratory rate changes. Values are represented as mean±SD. There are no 
inter-group differences. P value > 0.05. 
time  Group I (IPCAA)  Group II(EPCA) 
Mean  SD  Mean  SD 
Before 
15min 
30min 
4 hr 
12hr 
24hr 
20.4 
19.5 
19.0 
21.0 
18.7 
19.2 
±2.10 
±2.51 
±2.27 
±2.82 
±1.94 
±1.89 
20.8 
20.4 
20.1 
20.7 
20.0 
20.1 
±2.75 
±1.38 
±2.37 
±2.84 
±2.22 
±1.71 
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Table 5 :    Changes in FVC and FEV1, values are represented as mean ±SD.*P value 
                   <0.05 compared with baseline. 
 
  Pre- 
operative 
During 
pain  After 8 hr  After 24hr 
FVC 
Group I 
Group II 
 
FEV1 
Group I 
Group II 
 
3.68±0.67 
3.74±0.65 
 
 
2.60±0.71 
3.05±0.54 
 
0.64±0.23* 
0.76±0.24* 
 
 
0.46±0.35* 
0.54±0.28* 
 
2.33±0.43* 
2.04±0.53* 
 
 
1.63±0.51* 
1.61±0.45* 
 
2.81±0.44* 
2.57±0.62* 
 
 
1.94±0.53* 
2.15±0.58* 
 
Intravenous Group 
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Epidural group 
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Table 6 :  Arterial blood gas analysis. Values are represented as mean ±SD.  There are 
                 no inter-group differences.P value > 0.05. 
 
  Before  30min  4hr  24hr 
PH 
Group I 
Group II 
PaCO2(mmHg) 
Group I 
Group II 
PaO2(mmHg) 
Group I 
Group II 
 
7.41±0.02 
7.39±0.02 
 
38±3.27 
39±3.22 
 
88±10.47 
92±8.38 
 
7.40±0.01 
7.40±0.01 
 
39±2.23 
39±2.20 
 
89±8.69 
90±8.72 
 
7.40±0.02 
7.39±0.02 
 
38±3.17 
40±2.30 
 
89±7.09 
90±9.21 
 
7.39±0.03 
7.41±0.01 
 
38±2.08 
39±3.14 
 
90±8.31 
89±7.81 
 
Table 7 : Changes of beta-endorphin. Value are represented as  mean±SD.P value > 
                 0.05 compared to (pre-injection) 
 
Time 
Group I (IPCAA)  Group II(EPCA) 
Mean  SD  Mean  SD 
Before injection 
After  one hour 
22.8 
24.9 
±3.001 
±3.636 
21.6 
23.2 
±4.333 
±4.785 
 
 
Figure10 :  Changes in plasma level of beta-endorphin.  Values are represented as 
mean 
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Discussion 
  Postoperative  pain  is  a  great 
problem  that  may  cause  indirectly,  
adverse effects on various organ syst  -
ems.  The efficacy of clonidine admini -
stration continue to  be shown in  acute 
postoperative pain management.  It  has 
been  proved  that  epidural  clonidine  is 
an  adequate  alternative  to  opiates  in 
prolonging  the  duration  of  analgesia  
provided by local anaesthetics (cook et 
al., 1995). 
  Several  attempts  have  been 
made to compare epidural and systemic 
administration of clonidine  (De Kock et 
al.,1993). 
  This    study  investigated  the 
analgesic  and  respiratory  effects  of 
clonidine  when  administered  either  
intravenously  or  epidurally    through 
patient  controlled  analgesia  device. 
Clonidine was used  as a sole analgesic  
after surgical procedures involving  the 
abdomen  or  the  lower  extremities    to 
assess whether these two administration 
routes were clinically equivalent and to 
document differences in doses  required 
to achieve  the  same level  of  analgesia.  
In  the  present  study  intravenous  or 
epidural doses ranging from 250-350µg 
of  clonidine  were  given  as  an  initial 
dose or 350 -500  µg as a total dose for 
pain  relief  which  were  relatively  low 
doses if compared with other studies, as 
shown  by  Eisenach  et  al.,  1989)  who 
used  clonidine doses ranging from 100-
900µg  (100µg  increments)  in  patients 
following total knee,    arthroplasty or 
abdominal surgery. Also de kock et al., 
(1993) used total dose of clonidine from 
800-1000µg  in  his  study.    It  has  been 
proved that a fixed continuous infusion 
usually  overestimates  patient  require  -
ments  when  compared  to  patient-
controlled  analgesia  administration 
(Bouddreault  et    al.,1991).  Bonnet  et 
al.,(1989)    observed  that  epidural 
clonidine  2µg/kg  produced  brief  but 
significant  pain  relief  after  peripheral 
orthopedic surgery. 
  In this study,   both  intravenous 
and  epidural  clonidine  administration,   
using  patient-controlled  analgesia 
device, provided complete postoperative 
analgesia.    There  was  no  significant 
difference  in  pain  scores  between  the 
two    groups.    Reduction  of  clonidine 
requirements  by  the    use  of  epidural 
route  provides,    indirect  evidence  that 
analgesia  appears  to  be  better  after 
epidural than intravenous administration 
of  clonidine,  and  clearly  indicates  that 
spinal  cord  is  the  main  site  for  the 
analgesic  addition  of  clonidine  .    this 
finding  is  consistent  with  the  \work  of  
(Eisenach et al., 1993) and (Bernard et 
al.,1995) who used clonidine  epidurally 
and  intravenously  as  a  sole  analgesic 
agent for postoperative pain relief.   In 
contrast,  the findings of Carroll et al., 
(1993)  who reported that 150µg bolus 
dose  of  intravenous  clonidine  gives 
better  results than the same dose admi -
nistered  epidurally  
  Restriction in respiratory funct -
ions  following  surgical  trauma  was 
reported    by  different  studies  (Nishino 
et  al.,  1988)    and  it  is  common  belief 
that  good  pain  relief  reduces  the 
incidence  of  postoperative  pulmonary 
complications. 
  In this study, respiratory rate and 
blood  gases  were  unchanged  through 
the study in both groups.  No episodes 
of arterial oxygen saturation equal to or 
less than 95% were noted.  These data 
were  consistent  with  the  results  of 
(Berand et al., 1994) .  
  On  the  other  side  experimental 
studies  showed  that  systemic  clonidine 
had  produced  hypoxaemia  in  sheep 
(Eisenach and Dewan 1989)  and epid -
ural clonidine produced mild increase in 
arterial  pco2    (Eisenach  et  al.,  1993).    
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Restriction in  respiratory function  follo 
-wing  surgical  trauma  was  another 
similar  study  showing  that  intravenous 
but  not  intrathecal  administration  of 
alpha-2  adrenergic  agonist  results  in 
substantial  respiratory  depression 
(Sabbe et al.,1994) . 
         In the present study, the onset of 
pain  was  accompanied  by  a  severe 
restriction  of  pulmonary  function  test.  
The FVC and FEV1, were considerably 
and  significantly  reduced  compared  to 
preoperative levels in both groups.  Pain 
relief  with  clonidine  administration,  
resulted in a significant  improvement in 
this reduction.  However the values did 
not reach the preoperative level after 24 
hr post injection. 
  It  is  well  known  that  surgical 
trauma  increases  release  of  beta-
endorphin  level  in  plasma  (Kehlet, 
1987)  levy,1986    reported  that  plasma 
level  of  beta-endorphin  increases  three 
folds after surgical incision and remains 
elevated  well  in  the  postoperative 
period.   
         In  this  study,  plasma  levels  of 
beta-endorphin  were  increased  in  both 
groups  after  clonidine  injection  but 
levels were within the estimated range.  
The  normal  range  of  this  peptide  in 
plasma  between  16-48  pg/ml.  
Sxyfelbein  et  al.,  1985    found  that 
endorphin  concentration  was  inversely 
proportional  to  acute  pain,  i.e.  the 
greater the plasma  concentration of  B-
endorphin the  lower the  reported  pain. 
Plasma  concentration  of  B-endorphin  
may be considered as a good indicator 
of endogenous pain modulation. 
 
Conclusion  
Clonidine  proves  to  be  adequate 
alternative to opiates without their side 
effects,    like  respiratory  depression, 
itching, nausea  and vomiting.   It    may 
be  given  by  epidural  or  intravenous 
route for  postoperative analgesia.  The 
dose    of  clonidine  is  lower  by  the 
epidural  route,  indicating  that  it  has 
specific  action  on  sympathetic  neurons 
of the spinal cord. 
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 نيكستل ذيرىلا ىف ةنقحو ةيفاجلا ملأا جراخ نيذينىلكلا نقح نيب ةنراقولا
ضيرولا هيف نكحتي زاهج ةطساىب ةيحارجلا تايلوعلا ذعب اه ملاآ  
 
د  /  ىفطل ذوحأ داعس  * –   د  / رىصنه ذوحا داعس *  
د  / ذيعسلا ذوحه قراط  ** –   د  / حاتفلا ذبع ذوحه لهأ  ** – د  /  نيلعلا ذبع لهأ
 ىسره  **  
 رهزلأا تانب بطب ةيكينيلكلإا ايجىلىثابلاو ريذختلا ماسقأ  
 
 
              لباا     ا ي انم ااا  ًاالا ماا ا  ًاا لا ا لباامعلا  نإ (  باافلأ 2  )     اا دىنولا مااث 
إ ًف  ةئ هالا ا لبمعلا مظع   ع فن خ    ف ا لا ةا ناع ًنع ا ثأ  نو ب  مل ا  وا   بهد
.  
    ا دىنولا  امو ا ثأا    اب ةاد بمالا ىاا  وا نلا اااا  ا   ااغلاو   اا فبخلا  ما   باخ
    ىلا ًف   موو     مال ا   واا    اغب ءباصلا   غلا  زاافإ ًنعو  ف  لا ة ناع ًنع
 ة وااخلا يب ناعلا  عب .  
     ا  خا 00   ا  ا    اا خلا  ا  بض ا   ةا دبثلاو ًالوما ةائفل (  ةا عاخلا م اام ل باعن 
ا  اااخ لا ءبااانء   ةااا و ا  ا   )    نااانل مفااا  ا فاااص لا ًاااف يباااوااح مااااعل
 ةااعىاخ  ماا    ااع     عىاااخ  ًاالا  اىاااالو ًنفااالا اااااء او 20   ااض ا     ب   
 ة ناعلا  عب  مل ا   وا  ة ا  ل .  
    اا  ىلا ًااف  اام لا كاا اء  ااع    اا دىنولا ًاالوما ةااعىاخالا ياااخأ      اااخ  اا 
 ض االا  ة  اىب  مل ا ًف مو  لا ةخض  .  
     ا  ةا فبخلا  ما   باخ  ام لا كا اء  اع     دىنولا  ة دبثلا ةعىاخالا ياخأو
 ض االا ة  اىب  مل ا ًف مو  لا ةخض   اخ .  
    ة دب ااا      يباا  ع مه اا   ياااخأ  م  بااع ا  ااخ  ًااياالا ضاا اح ا  ااخ   ااعب
بثو ة لب       عاى  ًف ة    وو    ف و ادما ةنادو   لبب يازبغلا ةناد سب مل ة ب
 ب زانلا ًف .  
     ا  ااث ا  يااظ لا مال ا سب م  نب  اذإ ةوااخلا ءبه دا  عب 0     ض ااانل ًا عأ
ًالوأ ةعاح       ا دىنولا  ا    0    اااحواو   /    باخ وا  ا  ىلا  كا اء  اع ىان  
فدأب  بامعلا ءبا عإ ماهل  ااا  ماث ةعبا  فاصد ي ا  ًنع  ة فبخلا   ا   اع مهاا
   عاب ةخضالا ك اء 5  ااحواو     /  ةامنغ  ةا   ز ياا ف ضا   ةام ل لا ًاف ىان  
 به     مو م   عب 15        عىاخانل  ةم ل  .  
            باخ  ام لا ةاعىاخ  ًاف مالا تادب     ا دىنونل ةا نولا ةاعاخلا نا جئب  لا تل 
 ًف     دىنولا ءب عإ  عب ملأ تدب  مل ا ةح   ناو  ة فبخلا   ا  مانل  اع    عىااخالا
 هؤب عإ  عب    عىاخالا   ب قاف نب ا   ل  ولو هؤب عإ  .  ا غ  نب ا  و  مل  بض أو
 نأ  حوو    عىاخالا ًف   لبب يازبغلا ةناد ًف وا   ف  لا   ع  ًف  (  ةا ى  لا ةعالا 
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يىااامب   )  ًاااف     ااا دىنولا ءبااا عإ مااانل ةناااا لا تااادب  ةااا دبثلا  ًاااف يىااامب اااا فرلا ماااخوو
  عىاخالا   ةعبا   اعب ي اراف  ب زانلا ًف   ف و دما ةناد ب ا  هؤب عإ  عب     ملأ  
    عىاخالا   ب قاف نب ا   لو     دىنولا  ءب عإ    .  
 نىا ف ا  هبنا   شا ب   م  اب     ا دىنولا نا  و نلا ااا     ج   اد   اعبب   ما  ااعل
 ة وااخلا يب ناعلا  ناو  ةا ندبح   باثا    ىاحو     اع ض    مالا نىاو      ا دىنولا ةاعاح
    ىلا ًف   مو  ع  ة فبخلا   ا   بخ  مو اذإ .  
 
 
 